| Indicators | Browse All

Seer, Inc. (SEER)

Healthcare | Biotechnology | Redwood City, United States | NasdaqGS
2.17 USD
After hours: 2.16 -0.01 (-0.010%) ⇩ (July 13, 2026, 7:49 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 4:22 a.m. EDT

The investment case for Seer, Inc. is currently defined by a severe disconnect between activist-driven hype and deteriorating business fundamentals. While recent news headlines highlight a buyout bid and a 30% price surge, the underlying reality is starkly different. The company is hemorrhaging cash, with operating cash flow of -$48.5 million and free cash flow of -$31.7 million, while revenue has contracted by nearly 34%. The balance sheet, though showing a high current ratio due to massive cash reserves, is propped up by a company that cannot generate its own operating income. The long-term outlook is deeply concerning. Over the past four years, the stock has lost 93.6% of its value, reflecting a market that has repeatedly punished the company's inability to execute. Although the most recent annual report shows a nominal 14.7% gain, this follows three consecutive years of double-digit declines, indicating a structural failure in the business model rather than a turnaround. The negative forward P/E and negative ROE confirm that the core operations are destroying shareholder value. Short-term, the stock is trading at a discount to its 50-day moving average, suggesting the recent rally may be exhausting itself. The options market offers no clarity, with virtually no open interest to signal where smart money is positioning. Without a credible path to profitability or a confirmed deal closing that addresses the massive burn rate, the risk of further downside remains high. This is a speculative vehicle for activists, not a viable investment for capital preservation or growth.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.082217
AutoARIMA0.083934
AutoTheta0.084024
AutoETS0.084091

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 43%
H-stat 3.23
Ljung-Box p 0.000
Jarque-Bera p 0.399
Excess Kurtosis -0.81
Attribute Value
Sector Healthcare
Debt to Equity Ratio 9.536
Revenue per Share 0.268
Market Cap 119,309,976
Forward P/E -2.21
Beta 1.60
Website https://seer.bio

As of July 11, 2026, 4:22 a.m. EDT: Options activity is extremely thin with negligible open interest across all expirations. Implied volatility is elevated relative to the low premium prices, suggesting speculative pricing rather than genuine hedging or directional conviction. The lack of significant positioning at strikes above the current price indicates a lack of organized bullish speculation.


Info Dump

Attribute Value
52 Week Change 0.018779397
Address1 3,800 Bridge Parkway
Address2 Suite 102
All Time High 86.55
All Time Low 1.455
Ask 2.42
Ask Size 13
Audit Risk 4
Average Daily Volume10 Day 4,092,870
Average Daily Volume3 Month 921,606
Average Volume 921,606
Average Volume10Days 4,092,870
Beta 1.595
Bid 1.56
Bid Size 2
Board Risk 8
Book Value 4.385
City Redwood City
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 10
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.17
Current Ratio 17.728
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 2.19
Day Low 2.14
Debt To Equity 9.536
Display Name Seer
Earnings Call Timestamp End 1,778,704,200
Earnings Call Timestamp Start 1,778,704,200
Earnings Timestamp 1,778,702,400
Earnings Timestamp End 1,785,960,000
Earnings Timestamp Start 1,785,960,000
Ebitda -68,484,000
Ebitda Margins 0.0
Enterprise To Ebitda 0.355
Enterprise To Revenue -1.605
Enterprise Value -24,334,034
Eps Current Year -1.045
Eps Forward -0.98
Eps Trailing Twelve Months -1.24
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.8238
Fifty Day Average Change 0.3462001
Fifty Day Average Change Percent 0.18982351
Fifty Two Week Change Percent 1.8779397
Fifty Two Week High 2.41
Fifty Two Week High Change -0.24000001
Fifty Two Week High Change Percent -0.099585064
Fifty Two Week Low 1.55
Fifty Two Week Low Change 0.6200001
Fifty Two Week Low Change Percent 0.4000001
Fifty Two Week Range 1.55 - 2.41
Financial Currency USD
First Trade Date Milliseconds 1,607,092,200,000
Float Shares 40,105,743
Forward Eps -0.98
Forward P E -2.2142859
Free Cashflow -31,675,124
Full Exchange Name NasdaqGS
Full Time Employees 124
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.48701
Gross Profits 7,386,000
Has Pre Post Market Data 1
Held Percent Insiders 0.14475
Held Percent Institutions 0.51273996
Implied Shares Outstanding 54,981,551
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,020-12-04
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Long Name Seer, Inc.
Market us_market
Market Cap 119,309,976
Market State PREPRE
Max Age 86,400
Message Board Id finmb_548496461
Most Recent Quarter 1,774,915,200
Net Income To Common -70,489,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 119,309,965
Number Of Analyst Opinions 1
Open 2.16
Operating Cashflow -48,466,000
Operating Margins -6.1783004
Overall Risk 10
Payout Ratio 0.0
Phone 650 453 0000
Post Market Change -0.00970006
Post Market Change Percent -0.44700736
Post Market Price 2.1603
Post Market Time 1,783,986,545
Previous Close 2.17
Price Eps Current Year -2.0765553
Price Hint 4
Price To Book 0.49486887
Price To Sales Trailing12 Months 7.8669376
Profit Margins 0.0
Quick Ratio 16.687
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 2.19
Regular Market Day Low 2.14
Regular Market Day Range 2.14 - 2.19
Regular Market Open 2.16
Regular Market Previous Close 2.17
Regular Market Price 2.17
Regular Market Time 1,783,972,801
Regular Market Volume 362,062
Return On Assets -0.15038
Return On Equity -0.25517
Revenue Growth -0.336
Revenue Per Share 0.268
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 7
Shares Outstanding 54,981,551
Shares Percent Shares Out 0.0023999999
Shares Short 130,491
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 293,816
Short Name Seer, Inc.
Short Percent Of Float 0.0027
Short Ratio 0.9
Source Interval 15
State CA
Symbol SEER
Target High Price 4.0
Target Low Price 4.0
Target Mean Price 4.0
Target Median Price 4.0
Total Cash 166,672,000
Total Cash Per Share 3.031
Total Debt 23,028,000
Total Revenue 15,166,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.24
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.917075
Two Hundred Day Average Change 0.25292504
Two Hundred Day Average Change Percent 0.13193278
Type Disp Equity
Volume 362,062
Website https://seer.bio
Zip 94,065